
Merck's Dr Dave Maraldo explains that small-molecule platform agility and flexible conjugation capacity can help biologics manufacturing respond to research needs.
Biopharma continues to adopt single-use technologies, but also seeks more innovation and improvements in products.
Biopharma continues to adopt single-use technologies, but also seeks more innovation and improvements in products.
about 12 years ago
Innovations in Single-Use Bioprocessing Componentsabout 12 years ago
Optimizing Resin Performance with Disposable Chromatography Solutionsabout 12 years ago
Security of the Single-Use Supply Chain: Is Dual Sourcing the Answer?about 12 years ago
Trends in Single-Use Bioreactors





